DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo

ImmunoGen (NASDAQ: IMGN)

11.89 0.10 (0.85%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IMGN $11.89 0.85%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.70
Previous Close $11.79
Daily Range $11.60 - $12.04
52-Week Range $10.28 - $18.34
Market Cap $1.0B
P/E Ratio -14.20
Dividend (Yield) $0.00 (0.0%)
Volume 506,049
Average Daily Volume 878,180
Current FY EPS -$0.70





ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary

3 Beaten-Down Stocks Worth Buying

It isn't easy to find value in this market, but these three stocks could be making a strong case to rebound from their recent lows.

Risk And Reward Seem Pretty Balanced At Seattle Genetics

ImmunoGen Q4 Loss Narrower than Expected, Provides Guidance - Analyst Blog

ImmunoGen's (IMGN) CEO Daniel Junius on Q4 2014 Results - Earnings Call Transcript

Q4 2014 Immunogen Inc Earnings Conference Call (Webcast)

Why ImmunoGen (IMGN) Might Surprise This Earnings Season - Tale of the Tape

Why ImmunoGen (IMGN) Might Surprise This Earnings Season - Tale of the Tape

Will ImmunoGen's Q4 Earnings Disappoint Again?

ImmunoGen (IMGN) Soars: Stock Up 8.8% - Tale of the Tape

Stock To Watch: Immunogen (IMGN) In Perilous Reversal

3 Biotech Stocks Breaking Out With Big Volume

See More IMGN News...

IMGN's Top Competitors

IMGN $11.89 (0.85%)
Current stock: IMGN
AMGN $132.68 (-0.26%)
Current stock: AMGN
GILD $100.79 (-0.48%)
Current stock: GILD
BIIB $342.58 (-0.94%)
Current stock: BIIB